IJDVL Close
 

Figure 5: Evaluation of protection by sunscreens A and B in reconstructed skin exposed to increasing doses of DUVR. Sunscreens A and B had same SPF (15) but different SPF/UVA-PF ratio, < and >3, respectively. Products were applied onto samples before exposure to DUVR (0, 30, 50 or 70 J/cm 2 ). Note a good protection where product A has been applied compared to alterations observed in samples with product B. Scale bar: 50 and #956;m. Ovals :alterations in the epidermis. Bracket: the depth of dermal alterations. (Hematoxylin-Eosin-saffron staining, ×200)

Figure 5: Evaluation of protection by sunscreens A and B in reconstructed skin exposed to increasing doses of DUVR. Sunscreens A and B had same SPF (15) but different SPF/UVA-PF ratio, < and >3, respectively. Products were applied onto samples before exposure to DUVR (0, 30, 50 or 70 J/cm <sup>2</sup> ). Note a good protection where product A has been applied compared to alterations observed in samples with product B. Scale bar: 50 and #956;m. Ovals :alterations in the epidermis. Bracket: the depth of dermal alterations. (Hematoxylin-Eosin-saffron staining, ×200)